Cannabidiol
RxNorm 2045371
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2045371 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cannabidiol.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Cannabidiol
(Atom ID: 12252042)
PTPrescribable
Designated preferred name (PT):
Cannabidiol
(Atom ID: 60379)
FNPrescribable
Full form of descriptor (FN):
Cannabidiol (substance)
(Atom ID: 60383)
PTPrescribable
Designated preferred name (PT):
Cannabidiol-containing product
(Atom ID: 10798845)
FNPrescribable
Full form of descriptor (FN):
Product containing cannabidiol (medicinal product)
(Atom ID: 10810274)
Patient Education
Cannabidiol
Cannabidiol is used to control seizures in adults and children 1 year of age and older with Lennox-Gastaut syndrome (a disorder that begins in early childhood and causes seizures, developmental delays, and behavioral issues), Dravet syndrome (a disorder that begins in early childhood and causes seizures and later may lead to developmental delays and changes in eating, balance, and walking), or tuberous sclerosis complex (TSC; a genetic condition that causes tumors to grow in many organs). Cannabidiol is in a class of medications called cannabinoids. It is not known exactly how cannabidiol works to prevent seizure activity.
[Learn More]
* Please review the disclaimer below.